Atlas.
Sign inStart free trial
TWSTNASDAQ · US

Twist Bioscience Corp

Technology · Biological Products, (No Diagnostic Substances)

TechnologyBiological Products, (No Diagnostic Substances)
CEO
Emily Leproust
Founded
—
IPO Date
—
HQ
South San Francisco, CA, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$102.25 ▲ 215.7%
Last (1 Jul 2026) · $102
Period High · $102.88
Period Low · $0.00
52W: $102.25 – $102.88

Key Metrics

Share Price
$102.25
-0.6% today
Market Cap
$6.2B
P / E
—
EV / Revenue
15.9x
Revenue Growth
+20.3%
year-on-year
Gross Margin
—
Enterprise Value
$6.0B
52W High
$102.88
52W Low
$0.00
Avg Volume
1.7M
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
12 known institutional holders·$915M total on record·2026-Q1
BlackRock, Inc.
9.2%·$264M
State Street Corp
6.1%·$174M
Invesco Ltd.
3.6%·$103M
Fmr LLC
3.1%·$90M
Goldman Sachs Group Inc
2.8%·$81M
Geode Capital Management, LLC
2.5%·$72M
Dimensional Fund Advisors LP
1.3%·$37M
Point72 Asset Management, L.P.
1.1%·$32M
Bank Of America Corp
1.0%·$28M
Northern Trust Corp
0.9%·$25M
Jpmorgan Chase & Co
0.3%·$9M
Price T Rowe Associates Inc
0.1%·$3,341
Free Float
67.9%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for Twist Bioscience Corp
OverviewTwist Bioscience Corp share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow Twist Bioscience Corp generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsTwist Bioscience Corp's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityTwist Bioscience Corp executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsTwist Bioscience Corp's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for Twist Bioscience Corp, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for Twist Bioscience Corp aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersTwist Bioscience Corp valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for Twist Bioscience Corp with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for Twist Bioscience Corp — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial